No significant difference in overall survival was seen between treatment groups , with @ deaths ( @ % ) in the everolimus group and @ deaths ( @ % ) in the placebo group ( hazard ratio -LSB- HR -RSB- , @ ; @ % CI , @-@ @ ; P = @ ; median overall survival , @ months with everolimus , @ months with placebo ) .